By Elise Viebeck - 01/07/14 05:57 PM EST
Two senators are touting Medicare's plan to enhance oversight and crack down on fraud in Part D, which governs prescription drugs.
Sens. Tom CarperTom CarperOvernight Healthcare: McConnell unveils new Zika package | Manchin defends daughter on EpiPens | Bill includes M for opioid crisis Dems to GOP: Help us fix ObamaCare Overnight Finance: Trump promises millions of jobs | Obama taps Kasich to sell trade deal | Fed makes monetary policy video game | Trump vs. Ford MORE (D-Del.) and Tom CoburnTom CoburnRyan calls out GOP in anti-poverty fight The Trail 2016: Words matter Ex-Sen. Coburn: I won’t challenge Trump, I’ll vote for him MORE (R-Okla.) praised the plan in statements Tuesday, noting it would help save money in Medicare.
"For years, Medicare has lost millions of dollars due to fraudulent prescriptions for painkillers and other drugs," Carper said in a statement.
"This fraudulent activity is not only a financial drain on a vital federal program, but it is also harmful to those struggling with prescription drug abuse."
The proposal from the Centers for Medicare and Medicaid Services (CMS), due to take effect in January 2015, would give officials enhanced powers to identify and stop fraudulent prescriptions.
In one example, CMS will be able to easily spot and remove providers whose licenses to prescribe controlled substances have been revoked at the state level.
The Homeland Security Committee called for increased oversight of the program at a hearing in June.
The proposal was released in regulations on Monday.